Myeloid Cell Nuclear Differentiation Antigen (MNDA) Peptide
MNDA
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all MNDA products
- MNDA (Myeloid Cell Nuclear Differentiation Antigen (MNDA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KCEKGDKLRL FCLQLRTVDR KLKLVCGSHS FIKVIKAKKN KEGPMNVN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MNDA antibody,
Alternative Names: MNDA control peptide, MNDA antibody Blocking Peptide, Anti-MNDA Blocking Peptide, myeloid cell nuclear differentiation antigen Blocking Peptide, PYHIN3 Blocking Peptide - Purification
- Rabbit Anti-VEGFR2 (Ab-1214) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- MNDA (Myeloid Cell Nuclear Differentiation Antigen (MNDA))
- Synonyms
- PYHIN3 Peptide, A730048F03 Peptide, Ifi205b Peptide, myeloid cell nuclear differentiation antigen Peptide, interferon activated gene 211 Peptide, MNDA Peptide, Ifi211 Peptide
- Background
- The myeloid cell nuclear differentiation antigen (MNDA) is detected only in nuclei of cells of the granulocyte-monocyte lineage.MNDA may act as a transcriptional activator/repressor in the myeloid lineage. It plays a role in the granulocyte/monocyte cell-specific response to interferon. MNDA stimulates the DNA binding of the transcriptional repressor protein YY1.
- Molecular Weight
- 46 kDa
-
You are here:
